HCW Biologics Inc.
HCWB
$1.18
-$0.27-18.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 54.30K | 422.10K | 832.90K | 1.45M | 2.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.30K | 422.10K | 832.90K | 1.45M | 2.57M |
| Cost of Revenue | 43.40K | 337.60K | 666.20K | 1.10M | 1.61M |
| Gross Profit | 10.80K | 84.40K | 166.60K | 345.70K | 959.40K |
| SG&A Expenses | 10.36M | 8.90M | 9.59M | 19.34M | 22.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.74M | 14.29M | 15.09M | 26.08M | 30.73M |
| Operating Income | -15.68M | -13.87M | -14.26M | -24.63M | -28.16M |
| Income Before Tax | -7.96M | -12.05M | -11.40M | -24.75M | -30.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.96 | -12.05 | -11.40 | -24.75 | -30.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.96M | -12.05M | -11.40M | -24.75M | -30.02M |
| EBIT | -15.68M | -13.87M | -14.26M | -24.63M | -28.16M |
| EBITDA | -14.64M | -12.30M | -12.74M | -23.27M | -26.98M |
| EPS Basic | -11.79 | -13.96 | -16.07 | -25.44 | -31.50 |
| Normalized Basic EPS | -5.60 | -6.63 | -8.21 | -16.16 | -18.83 |
| EPS Diluted | -11.79 | -13.96 | -16.07 | -25.44 | -31.50 |
| Normalized Diluted EPS | -5.60 | -6.63 | -8.21 | -16.16 | -18.83 |
| Average Basic Shares Outstanding | 8.54M | 6.21M | 4.90M | 4.07M | 3.88M |
| Average Diluted Shares Outstanding | 8.54M | 6.21M | 4.90M | 4.07M | 3.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |